Provided by Tiger Fintech (Singapore) Pte. Ltd.

Anebulo Pharmaceuticals, Inc.

0.9500
-0.0600-5.94%
Volume:4.00K
Turnover:3.98K
Market Cap:39.03M
PE:-3.26
High:1.05
Open:1.05
Low:0.9500
Close:1.01
Loading ...

BRIEF-Anebulo Pharmaceuticals Inc Files For Resale Of Up To 15.15 Million Shares By The Selling Stockholders

Reuters
·
04 Mar

Anebulo Pharmaceuticals Inc Files for Resale of up to 15.15 Mln Shares by the Selling Stockholders - SEC Filing

THOMSON REUTERS
·
04 Mar

Anebulo Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
15 Feb

Anebulo Pharmaceuticals reports Q4 EPS (9c) vs. (11c) last year

TIPRANKS
·
15 Feb

Anebulo Pharmaceuticals Q2 2025 GAAP EPS $(0.09) Misses $(0.08) Estimate

Benzinga
·
15 Feb

Anebulo Pharmaceuticals, Inc. Q2 Operating Expenses USD 2.6 Million

THOMSON REUTERS
·
15 Feb

Press Release: Anebulo Pharmaceuticals Reports Second Quarter Fiscal Year 2025 Financial Results and Recent Updates

Dow Jones
·
15 Feb

Anebulo Pharmaceuticals Inc expected to post a loss of 8 cents a share - Earnings Preview

Reuters
·
07 Feb

Anebulo Pharmaceuticals Leads This Trio Of US Penny Stocks

Simply Wall St.
·
05 Feb

Anebulo Pharmaceuticals collaborates with FDA to advance selonabant

TIPRANKS
·
23 Dec 2024

Anebulo Pharmaceuticals: Entered Stock Purchase Agreement for Issuance & Sale of 15.2 Mln Shares of Common Stock for $15 Mln

THOMSON REUTERS
·
23 Dec 2024

Anebulo Pharmaceuticals Inc: Plans to Begin Its Phase I Sad Study of Iv Selonabant in Healthy Adults in 1H25

THOMSON REUTERS
·
23 Dec 2024

Anebulo Pharmaceuticals Announces Positive Regulatory Update for Selonabant in Acute Cannabis-Induced Toxicity in Children and Capital Raise

THOMSON REUTERS
·
23 Dec 2024

Anebulo Pharmaceuticals: Intends to Modify Loan and Security Agreement by Reducing Maximum Loan Size to About $3 Mln

THOMSON REUTERS
·
23 Dec 2024

Anebulo Pharmaceuticals Announces Positive Regulatory Update for Selonabant in Acute Cannabis-Induced Toxicity in Children and Capital Raise

Business Wire
·
23 Dec 2024

Anebulo Pharmaceuticals Price Target Maintained With a $8.00/Share by Benchmark

Dow Jones
·
19 Nov 2024

Anebulo Pharmaceuticals Advances Cannabis Toxicity Solutions

TIPRANKS
·
16 Nov 2024

Anebulo Pharmaceuticals Inc reports results for the quarter ended September 30 - Earnings Summary

Reuters
·
14 Nov 2024

Anebulo Pharmaceuticals Q1 EPS $(0.08) Up From $(0.10) YoY

Benzinga
·
14 Nov 2024

Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2025 Financial Results and Recent Updates

THOMSON REUTERS
·
14 Nov 2024